Study explains how part of the nucleolus evolved
A single protein can self-assemble to build the scaffold for a biomolecular condensate that makes up a key nucleolar compartment.
A single protein can self-assemble to build the scaffold for a biomolecular condensate that makes up a key nucleolar compartment.
SMART researchers find the enzyme RlmN, which directly senses chemical and environmental stresses, can be targeted in drug development.
Whitehead Institute researchers find many transcription factors bind RNA, which fine-tunes their regulation of gene expression, suggesting new therapeutic opportunities.
A new technology called RIBOmap can give researchers valuable insight into how protein production in animal and human tissue is altered in disease.
A pilot-scale system, enabled by an $82 million award from the FDA, aims to accelerate the development and production of mRNA technologies.
The first RNA-guided DNA-cutting enzyme found in eukaryotes, Fanzor could one day be harnessed to edit DNA more precisely than CRISPR/Cas systems.
The new diagnostic, which is based on analysis of urine samples, could also be designed to reveal whether a tumor has metastasized.
The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin.
The global health care company Sanofi is providing $25 million to advance RNA research.
Using these RNA-delivery particles, researchers hope to develop new treatments for cystic fibrosis and other lung diseases.
Using this approach, researchers hope to deliver therapeutic RNA molecules selectively to cancer cells or other target cells.
Study reveals key cell structures and gene expression changes near amyloid plaques and tau tangles in mouse brain tissue.
When she’s not analyzing data about her favorite biomolecule, senior Sherry Nyeo focuses on improving the undergraduate experience at MIT.
A new study identifies cells that are the most vulnerable within a brain structure involved in mood and movement.
“Single-cell profiling” is helping neuroscientists see how disease affects major brain cell types and identify common, potentially targetable pathways.